Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Cash from Investing Activities (2016)

Lixte Biotechnology Holdings' Cash from Investing Activities history spans 7 years, with the latest figure at $1.1 million for Q3 2016.

  • For Q3 2016, Cash from Investing Activities rose 75.69% year-over-year to $1.1 million; the TTM value through Dec 2016 reached $104095.0, changed N/A, while the annual FY2025 figure was -$3.2 million, N/A changed from the prior year.
  • Cash from Investing Activities reached $1.1 million in Q3 2016 per LIXT's latest filing, up from -$183354.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.1 million in Q3 2016 to a low of -$1.1 million in Q1 2015.
  • Average Cash from Investing Activities over 5 years is $493.07, with a median of -$8043.0 recorded in 2012.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 574557.45% in 2012, then plummeted 804300.0% in 2014.
  • A 5-year view of Cash from Investing Activities shows it stood at -$8043.0 in 2012, then dropped by 0.01% to -$8044.0 in 2013, then changed by 0.0% to -$8044.0 in 2014, then surged by 7558.69% to $599977.0 in 2015, then soared by 75.69% to $1.1 million in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Cash from Investing Activities are $1.1 million (Q3 2016), -$183354.0 (Q2 2016), and -$766678.0 (Q1 2016).